NFE2L2 and diabetes mellitus: Consistently, it was shown that Nrf2−/− mice are more susceptible to cardiac remodeling, and Nrf2 is protective against pressure overload-mediated, ischemia-induced, diabetes-mediated, and anticancer drug-mediated cardiac remodeling [118].